FRE

FIREBRICK FPO [FRE]
Firebrick Pharma Limited engages in the development and commercialization of povidone-iodine (PVP-I) products under the Nasodine brand in Asia, North America, Europe, and internationally. It offers nasal spray PVP-I products for the treatment of common cold. The company was incorporated in 2012 and is based in Melbourne, Australia.
Healthcare · ASX Small Cap
$0.0300 +0.0%

Updated 22 Jul 2026 · Signals refresh every scan

Get alerts when FRE triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Track FRE — Free

Active Signals

Bullish Signals

  • RSI drifting toward oversold territory — worth watching
  • MACD momentum is picking up steam
  • Volatility is contracting — like a spring being compressed, breakouts often follow
  • Low cash runway (3 quarters) - dilution risk
  • Revenue in sharp decline (-53%)
  • Near 52-week low (4% of range)
  • Micro-cap ($5-20M) - high risk
  • Capital raise activity (1 events)
  • CANSLIM S: Tight float (50%)
  • Sentiment is mixed — no strong consensus either way
  • This one has been in freefall — down 51% over the past year
  • Altman Z-Score distress zone (1.19 < 1.81, low-confidence approx)
  • Low-priced stock risk ($0.030)
  • Beneish M-Score 11.21 > -1.78: likely earnings manipulation
  • RBA hiking (-3pts)
  • Calendar: Quarterly 4C in 11d (+3pts)

Risk Signals

  • Trading below both moving averages — the trend is working against this one
  • Below the 200-day average — the long-term trend is still working against it
  • Piotroski F-Score weak (3/9, low-confidence approx)
  • Not enough chatter to gauge sentiment — defaulting to neutral
  • Revenue declining at -53% — the top line is shrinking
  • The bigger volume days are the down days — volume-weighted momentum is negative (-1.96%/day)
Ask Scout AI about FRE
"What's driving FRE today?" "How does FRE compare to peers?" "Key risks for FRE?"
3 free messages/day · Unlimited with Pro

Recent Catalysts

NONE Change of Address
NONE Results of General Meeting
NONE Cleansing Notice
MEDIUM Nasodine Composition Patent Granted in New Zealand

Recent ASX Announcements

2026-07-14 Change of Address
2026-06-22 Results of General Meeting
2026-06-02 Nasodine Composition Patent Granted in New Zealand
2026-06-01 Cleansing Notice
2026-06-01 Application for quotation of securities - FRE

Key Metrics

$8.6M
Market Cap
257K
Avg Volume
1.9x
Vol Ratio
$0.03 — $0.09
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-142.7%
ROE
N/A
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandpassFloat: 50%
LLeader vs LaggardlaggardRS: -23
IInstitutional Sponsorshipinsufficient_dataInst: 0%
MMarket DirectionneutralNeutral

Sector: Healthcare

101 tickers in this sector

View all Healthcare signals →Browse all ASX tickers A–Z →
Related Tickers
IDT +28.1%ADR +27.3%LDX +23.8%EYE +17.4%ECS -16.7%
Compare:FRE vs IDTFRE vs ADRFRE vs LDX
Scout Pro — Deeper Analysis for FRE
Try Pro free for 30 days
Share this analysis

Track FRE and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required